• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鞘内注射巴氯芬治疗的最佳实践:剂量与长期管理

Best Practices for Intrathecal Baclofen Therapy: Dosing and Long-Term Management.

作者信息

Boster Aaron L, Adair Roy L, Gooch Judith L, Nelson Mary Elizabeth S, Toomer Andrea, Urquidez Joe, Saulino Michael

机构信息

Adult Neurology, OhioHealth Neurological Physicians, Columbus, OH, USA.

Adult Physical Medicine & Rehabilitation, Advocate Christ Medical Center, Oak Lawn, IL, USA.

出版信息

Neuromodulation. 2016 Aug;19(6):623-31. doi: 10.1111/ner.12388. Epub 2016 Jul 19.

DOI:10.1111/ner.12388
PMID:27433993
Abstract

INTRODUCTION

Intrathecal baclofen (ITB) therapy aims to reduce spasticity and provide functional control.

METHOD

An expert panel consulted on best practices.

RESULTS

Pump fill and drug delivery can be started intraoperatively, with monitoring for at least eight hours. Initiate with the 500 mcg/mL concentration. The starting daily dose should be twice the effective bolus screening dose, or the screening dose if the patient had a prolonged response (greater than eight hours) or negative reactions. Oral antispasmodics can be weaned, one drug at a time beginning with oral baclofen after ITB begins. Assessment should occur within 24 hours of a dose change. For adults, daily dose increases may be 5% to 15% once every 24 hours for cerebral-origin spasticity and 10% to 30% once every 24 hours for spinal-origin spasticity. Daily dose increases can be 5% to 15% once every 24 hours for children. Inpatients should be assessed at least every 24 hours and receive rehabilitation. Step dosing can be used for outpatients who cannot return daily. Dosing options include simple continuous dosing, variable 24-hour flex dosing, or regularly scheduled boluses. Patients/caregivers should understand the care plan, responsibilities, and possible side-effects. Low-reservoir alarm dates and refill schedules should be written down, along with emergency contact information. A higher concentration at refill can extend refill intervals, and a bridge bolus must be programmed. Time changes may affect flex dosing. Pump replacement should be scheduled at least three months in advance.

CONCLUSIONS

ITB dosing is multistep and individualized.

摘要

引言

鞘内注射巴氯芬(ITB)疗法旨在减轻痉挛并实现功能控制。

方法

一个专家小组就最佳实践进行了咨询。

结果

泵填充和药物输送可在术中开始,监测至少八小时。从500 mcg/mL浓度开始。起始日剂量应为有效推注筛查剂量的两倍,或者如果患者有延长反应(超过八小时)或不良反应,则为筛查剂量。口服抗痉挛药可以逐渐减量,在ITB开始后从口服巴氯芬开始,一次一种药物。应在剂量改变后24小时内进行评估。对于成年人,对于脑源性痉挛,每日剂量增加可为每24小时5%至15%,对于脊髓源性痉挛,每24小时10%至30%。儿童每日剂量增加可为每24小时5%至15%。住院患者应至少每24小时评估一次并接受康复治疗。对于不能每日复诊的门诊患者可采用逐步给药。给药选项包括简单连续给药、可变24小时灵活给药或定期推注。患者/护理人员应了解护理计划、责任和可能的副作用。低储液器警报日期和补充时间表应记录下来,连同紧急联系信息。补充时使用较高浓度可延长补充间隔,并且必须设置桥接推注。时间变化可能会影响灵活给药。泵更换应至少提前三个月安排。

结论

ITB给药是多步骤且个体化的。

相似文献

1
Best Practices for Intrathecal Baclofen Therapy: Dosing and Long-Term Management.鞘内注射巴氯芬治疗的最佳实践:剂量与长期管理
Neuromodulation. 2016 Aug;19(6):623-31. doi: 10.1111/ner.12388. Epub 2016 Jul 19.
2
Best Practices for Intrathecal Baclofen Therapy: Screening Test.鞘内注射巴氯芬治疗的最佳实践:筛查测试。
Neuromodulation. 2016 Aug;19(6):616-22. doi: 10.1111/ner.12437. Epub 2016 Jul 19.
3
Best Practices for Intrathecal Baclofen Therapy: Troubleshooting.鞘内注射巴氯芬治疗的最佳实践:故障排除
Neuromodulation. 2016 Aug;19(6):632-41. doi: 10.1111/ner.12467. Epub 2016 Jul 19.
4
Best Practices for Intrathecal Baclofen Therapy: Patient Selection.鞘内注射巴氯芬治疗的最佳实践:患者选择
Neuromodulation. 2016 Aug;19(6):607-15. doi: 10.1111/ner.12447. Epub 2016 Jul 19.
5
Long-Term Dosing of Intrathecal Baclofen in the Treatment of Spasticity After Acquired Brain Injury.鞘内注射巴氯芬长期给药治疗获得性脑损伤后痉挛状态
PM R. 2017 Jun;9(6):556-562. doi: 10.1016/j.pmrj.2016.12.006. Epub 2017 Jan 8.
6
Intrathecal Baclofen therapy in Germany: Proceedings of the IAB-Interdisciplinary Working Group for Movement Disorders Consensus Meeting.德国鞘内注射巴氯芬疗法:IAB 运动障碍跨学科工作组共识会议纪要
J Neural Transm (Vienna). 2015 Nov;122(11):1573-9. doi: 10.1007/s00702-015-1425-1. Epub 2015 Jul 16.
7
Intrathecal baclofen for spasticity management: a comparative analysis of spasticity of spinal vs cortical origin.鞘内注射巴氯芬治疗痉挛:脊髓源性与皮质源性痉挛的对比分析
J Spinal Cord Med. 2010;33(1):16-21. doi: 10.1080/10790268.2010.11689670.
8
Intrathecal Baclofen Therapy in Patients With Multiple Sclerosis: Improved Outcomes and Reduced Costs Through Identification of Catheter Malfunction.鞘内注射巴氯芬治疗多发性硬化症:通过识别导管故障改善结果并降低成本。
Neuromodulation. 2019 Oct;22(7):839-842. doi: 10.1111/ner.12974. Epub 2019 Jun 3.
9
Intrathecal baclofen bolus dosing and catheter tip placement in pediatric tone management.鞘内注射巴氯芬大剂量给药及导管尖端放置在儿童肌张力管理中的应用
Phys Med Rehabil Clin N Am. 2015 Feb;26(1):89-93. doi: 10.1016/j.pmr.2014.09.011.
10
Treatment of severe, disabling spasticity with continuous intrathecal baclofen therapy following acquired brain injury: the experience of a tertiary institution in Singapore.脑损伤后采用鞘内持续注射巴氯芬疗法治疗严重致残性痉挛:新加坡一家三级医疗机构的经验
Singapore Med J. 2016 Jan;57(1):8-12. doi: 10.11622/smedj.2016005.

引用本文的文献

1
Use of O-arm to place an intrathecal catheter through a bony fusion mass: case report.使用O型臂通过骨融合块放置鞘内导管:病例报告。
Front Rehabil Sci. 2025 May 22;6:1530801. doi: 10.3389/fresc.2025.1530801. eCollection 2025.
2
Neurological adverse events associated with baclofen: A disproportionality analysis based on FDA Adverse Event Reporting System.与巴氯芬相关的神经系统不良事件:基于美国食品药品监督管理局不良事件报告系统的不成比例性分析。
SAGE Open Med. 2025 Apr 28;13:20503121251331812. doi: 10.1177/20503121251331812. eCollection 2025.
3
A Simplified Procedure for Intrathecal Baclofen Catheter Replacement Through a Granulation Tunnel Using a 16-Gauge Peripheral Vein Catheter.
一种使用16号外周静脉导管经肉芽组织通道进行鞘内巴氯芬导管置换的简化方法。
Cureus. 2025 Jan 19;17(1):e77686. doi: 10.7759/cureus.77686. eCollection 2025 Jan.
4
Real-world impact of intrathecal baclofen therapy: the benefits of neteka on patient outcomes, caregiver burden, and cost efficiency.鞘内注射巴氯芬疗法的现实世界影响:Neteka对患者预后、照料者负担和成本效益的益处。
Neurol Sci. 2025 May;46(5):2229-2234. doi: 10.1007/s10072-024-07965-z. Epub 2025 Jan 13.
5
Multimodal surgical strategy for mixed refractory hypertonia in a patient with cerebral palsy: C1-2 puncture and pectoral pocket for baclofen pump implantation following lumbosacral ventral-dorsal rhizotomy. Illustrative case.脑瘫患者混合性难治性肌张力亢进的多模式手术策略:腰骶部腹背根切断术后行C1-2穿刺及胸大肌下植入巴氯芬泵。病例报告。
J Neurosurg Case Lessons. 2024 Dec 2;8(23). doi: 10.3171/CASE24427.
6
Intrathecal baclofen efficacy for managing motor function and spasticity severity in patients with cerebral palsy: a systematic review and meta-analysis.鞘内注射巴氯芬对脑瘫患者运动功能和痉挛严重程度的管理效果:一项系统评价和荟萃分析。
BMC Neurol. 2024 Apr 27;24(1):143. doi: 10.1186/s12883-024-03647-7.
7
Utilizing combination intrathecal baclofen and analgesic medication to manage spasticity and pain in patients with pediatric-onset disability: Case series.利用鞘内注射巴氯芬联合镇痛药物治疗儿童期起病残疾患者的痉挛和疼痛:病例系列研究。
J Pediatr Rehabil Med. 2024;17(1):57-66. doi: 10.3233/PRM-220100.
8
Dose escalation in intrathecal baclofen therapy based on disease etiology: Can an target dose be established? A ten-year follow-up study.基于疾病病因的鞘内注射巴氯芬治疗剂量递增:能否确定目标剂量?一项十年随访研究。
J Spinal Cord Med. 2025 Mar;48(2):283-289. doi: 10.1080/10790268.2023.2266614. Epub 2023 Nov 20.
9
Spasticity and movement disorders in cerebral palsy.脑性瘫痪的痉挛和运动障碍。
Childs Nerv Syst. 2023 Oct;39(10):2877-2886. doi: 10.1007/s00381-023-06045-5. Epub 2023 Jul 6.
10
Assessment of Health Care Costs and Total Baclofen Use Associated With Targeted Drug Delivery for Spasticity.评估与痉挛的靶向药物递送相关的医疗保健成本和总巴氯芬使用量。
Neuromodulation. 2023 Aug;26(6):1247-1255. doi: 10.1016/j.neurom.2023.01.017. Epub 2023 Mar 6.